Australian innovators in 3D printing and precision medicine can now apply for finance after a call was put out for expressions of interest for a slice of $35 million in government funding.
The first $5m will consist of $3m for ideas in precision medicine, a new approach for disease treatment and prevention, and $2m for ways to develop 3D anatomical printing for everyday medical use.
The first $5m will be available through the Biotech Horizons program and will be managed by MTPConnect the medical technologies and pharmaceuticals industry growth centre.
MTPConnect chief executive Sue MacLeman said 3D anatomical printing and precision medicine had been identified for the first share of funding because Australia punched above its weight in those areas.
- Expressions of interest open: 1 November 2017
- Closing date for EOI: 10 December 2017
- Closing date for stage 2 applications: 15 January 2018
- Announcement of successful applications: expected late February 2018
For more information and EOI forms, visit www.mtpconnect.org.au/biomedtechhorizons.